What is the impact of immunosuppressive treatment on the post-transplant renal osteopathy?

about

Mechanism and Treatment Strategy of Osteoporosis after Transplantation Osteoporosis after renal transplantation.Implications of the Interaction Between miRNAs and Autophagy in Osteoporosis.

P2860

Q26798296-400F44A6-4856-4C5E-8398-81BFA773A902 Q38266612-003F7038-7F59-4112-A898-093ADA5A75FB Q38753100-60E969EE-EF78-4374-97E9-F7A70F4871DD

P2860

What is the impact of immunosuppressive treatment on the post-transplant renal osteopathy?

Item

http://www.wikidata.org/entity/Q38161821

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

What is the impact of immunosu ...... t-transplant renal osteopathy?

@en

type

Item

label

What is the impact of immunosu ...... t-transplant renal osteopathy?

@en

prefLabel

What is the impact of immunosu ...... t-transplant renal osteopathy?

@en

P1476

What is the impact of immunosu ...... t-transplant renal osteopathy?

@en

P2093

Kristina Blaslov

http://www.w3.org/2001/XMLSchema#string

Lea Katalinic

http://www.w3.org/2001/XMLSchema#string

Nikolina Basic-Jukic

http://www.w3.org/2001/XMLSchema#string

Petar Kes

http://www.w3.org/2001/XMLSchema#string

Ruzica Smalcelj

http://www.w3.org/2001/XMLSchema#string

P2860

Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival

Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis

Defining the role of mTOR in cancer

Skeletal and hormonal effects of magnesium deficiency

Upstream and downstream of mTOR

The tuberous sclerosis complex

Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption.

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.

Benefit-risk assessment of sirolimus in renal transplantation.

P304

1019-1024

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11255-013-0596-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Goce Spasovski

P577

2013-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24217803

http://www.w3.org/2001/XMLSchema#string

What is the impact of immunosuppressive treatment on the post-transplant renal osteopathy?

about

P2860

P2860

What is the impact of immunosuppressive treatment on the post-transplant renal osteopathy?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698